May 22nd - World Pre-Eclampsia Day
Early diagnosis of Pre-Eclampsia can save lives.
International Woman's Day - 8th March 2022
International Women’s Day is a time to celebrate the social, economic, cultural and political achievements of women everywhere. This year, the focus is on how to #breakthebias
Cerca Biotech
Cerca Biotech is the European subsidiary of Shuwen Biotech, who you might already recognise as being a highly reputable and innovative molecular and point of care diagnostics organisation.
Mamma Typer®
it’s time to take the stage.
MammaTyper® is a new tool for subtyping breast cancer.
READ MORE +
A rapid, simple, Point Of Care screening test for urinary congophilia.
READ MORE +ABOUT US
Cerca Biotech
Cerca Biotech is the European subsidiary of Shuwen Biotech, a highly reputable and innovative molecular and point of care diagnostics organisation. Shuwen and Cerca are passionate about healthcare and are working to create world-leading innovations in the fields of Oncology and Women’s Health.
High-performance test
Quantitative RT-qPCR assay (CE marked IVD)
- Highly reproducible biomarker assessment
- Reliable results through standardized biomarker detection
- Accurate stratification of breast cancer tumors into St Gallen subtypes
Promising clinical utility
Clinical value validated in numerous performance evaluation studies
- Outperforms IHC by accurate Ki-67 determination
- Provides information on patient‘s prognosis
- Accurate subtyping supports treatment decisions
Easy-to-use
Clinical value validated in numerous performance evaluation studies
- Reliable method for any molecular pathology laboratory
- Validated for multiple qPCR instruments*
- From resection or core needle biopsy FFPE sample to result within 6 hours FFPE = formalin fixed paraffin embedded
NEWS
Recent article and news
World Pre Eclampsia Day (May 22nd)
Early diagnosis of Pre-Eclampsia can save lives. Yet, definitive detection of this potentially fatal condition can be delayed or difficult to access under current testing regimes. To help combat this issue, Cerca Biotech is launching a new, rapid point-of-care test designed for use in maternity departments and primary care settings.
MammaTyper® announces registration in Italy
We are really pleased to announce that MammaTyper® has been registered by the Ministero della Salute in Italy. This marks a key step towards bringing this innovative, RT-qPCR test to the Italian market and helping women who have been diagnosed with breast cancer. This announcement follows our earlier news that Padua-based firm AB Analytica will be the exclusive distributor for MammaTyper® in Italy.
March 8th - International Women’s Day
International Women’s Day is a time to celebrate the social, economic, cultural and political achievements of women everywhere. This year, the focus is on how to #breakthebias that women see in many aspects of their lives.